LEARNER- Low dosE AspiRiN prEterm tRial (Angola) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

LEARNER- Low dosE AspiRiN prEterm tRial (Angola) — Stella

Home/Sickle Cell Disease/

View on ClinicalTrials.gov

Recruiting

Back to Sickle Cell Disease trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Angola

Instituto Nacional de Investigação Em Saúde, Luanda

Key details

Phase

Early testing / Safety & dosing

Sponsor

Instituto Nacional de Investigacao em Saude, Angola

Collaborators

FUNDACIÓN BANCARIA CAIXA D'ESTALVIS I PENSIONS DE BARCELONA, Calouste Gulbenkian Foundation

Enrollment target

~450 participants

Started

March 2024

Primary completion

March 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Age range

15 Years and older

Sex

Female only

Last updated May 2024